Published in Cardiovascular Business Week, April 10th, 2007
"The encouraging results from the first 30 patients of ABSORB suggest that drug-eluting bioabsorbable stent technologies...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.